knowledge -WSS

knowledge

author：entertainment 2025-09-30 20:35:22 - browse：952

LIONEL BONAVENTURE/AFP via Getty Images

On Tuesday, Duke Health and Microsoft announced a five-year partnership that will support artificial intelligence applications in medicine, with a focus on building out infrastructure such as cloud-based data platforms.

Duke Health and Microsoft are both members of the Coalition for Health AI, a group of companies, hospitals, and federal agencies that formed late last year to develop guidelines for the responsible use of AI in medicine. “We have all these operational things we want to do in the health system, and we also have an academic interest in trustworthy AI,” said Jeffrey Ferranti, senior vice president and chief digital officer of Duke Health.

So Duke and Microsoft will collaborate within the newly-established Duke Health AI Innovation Lab and Center of Excellence, where researchers can develop new AI tools “while paying attention to some of the things that could go wrong,” said Ferranti. “Because there are a lot of things that can go wrong as we introduce new technology.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

WSS

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Supreme Court to hear if Covid misinformation is protected speech

STAT reporters are Pulitzer Prize finalists for investigative reporting

Medical device trials still don't enroll enough women, study finds

knowledge

knowledge

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Apple is now the first public company to be valued at $3 trillion

The system is set up to fail children with medical complexity

Medicare details structure of new drug price negotiation program

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Duchenne breakthrough therapy leaves behind pioneering families

The United States must get value

Supreme Court strikes down use of affirmative action

Lilly's Alzheimer's drug donanemab backed by FDA advisers

entertainment

5 takeaways from STAT's examination of Zynex Medical

Cherokee Nation medical school graduates its first class

Readers discuss the intersection of pregnancy and addiction

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Cherokee Nation medical school graduates its first class

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

entertainment

knowledge

explore

knowledge